Výsledky vyhledávání - "O. F. Ballester"

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

Autor: Alan Lichtenstein, Sebastian George, Alan Keller, Rob Knight, James R. Berenson, Joseph F. Simeone, Meletios A. Dimopoulos, O. F. Ballester, Dirk J. Reitsma, Hillary Blacklock, John J. Seaman, Richard Bryan Bell, Roldolfo Bordoni, Alan Lipton, Lester Porter, Michael J. Kovacs, Maika Heffernan

Publikováno v: Journal of Clinical Oncology. 16:593-602

PURPOSE To determine the efficacy and safety of 21 monthly cycles of pamidronate therapy in patients with advanced multiple myeloma. PATIENTS AND METHODS Patients with stage III myeloma and at least one lytic lesion received either placebo or pamidro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223f143845a5731cc2deddeaaad49a02
https://doi.org/10.1200/jco.1998.16.2.593

Zobrazit plný text záznamu

Nephrotoxicity of High-Dose Ifosfamide/Carboplatin/Etoposide in Adults Undergoing Autologous Stem Cell Transplantation

Autor: John W. Hiemenz, O. F. Ballester, Zorsky Pe, Todd Mattox, Karen K. Fields, Dimitrios P. Agaliotis, G. J. Elfenbein, Janelle Perkins, Raquel Rosen, Steven C. Goldstein

Publikováno v: The American Journal of the Medical Sciences. 314:292-298

The objective of this study was to evaluate nephrotoxicity in adult patients treated with high-dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell transplantation. We conducted a retrospective analysis of clinical and laborat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e16d09dafa1d4db232d1be0a281ce4ea
https://doi.org/10.1016/s0002-9629(15)40225-3

Zobrazit plný text záznamu

Randomized clinical trials for hematopoietic stem cell transplantation: lessons to be learned from the European experience

Autor: Gary H. Lyman, O F Ballester, Sejal S. Kuthiala

Publikováno v: Bone Marrow Transplantation. 37:219-221

We evaluated the number and characteristics of randomized controlled trials (RCTs) addressing hematopoietic stem cell transplantation (HSCT) for patients with hematological malignancies, comparing the productivity of US and Europe. A MEDLINE search w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c9f58781ce0fa2a1c1747fc6aad2513
https://doi.org/10.1038/sj.bmt.1705230

Zobrazit plný text záznamu

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

Autor: Alan Keller, Dirk J. Reitsma, Michael J. Kovacs, Lester Porter, James R. Berenson, Sebastian George, Joseph F. Simeone, John J. Seaman, Roldolfo Bordoni, Alan Lichtenstein, Meletios A. Dimopoulos, Allan Lipton, Maika Heffernan, Robert Knight, Richard Bell, Hilary A. Blacklock, O. F. Ballester

Publikováno v: New England Journal of Medicine. 334:488-493

Background Skeletal complications are a major clinical manifestation of multiple myeloma. These complications are caused by soluble factors that stimulate osteoclasts to resorb bone. Bisphosphonates such as pamidronate inhibit osteoclastic activity a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b1ea5d9dc1dc04ca5579d2b5145a08b
https://doi.org/10.1056/nejm199602223340802

Zobrazit plný text záznamu

High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma

Autor: O. F. Ballester, C. Klein, Gary H. Lyman, Lynn C. Moscinski, Hussain I. Saba, J. V. Chaney, A. S. D. Spiers

Publikováno v: Blood. 83:1903-1908

Interleukin-6 (IL-6) is a multifunctional cytokine postulated to play a central role as a growth factor for multiple myeloma (MM). We evaluated the spontaneous secretion of IL-6 in supernatants of Ficoll-Hypaque-- enriched bone marrow (BM) cultures f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::147133e07ebda8586c7b0d534d182571
https://doi.org/10.1182/blood.v83.7.1903.1903

Zobrazit plný text záznamu

High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma

Autor: O F, Ballester, L C, Moscinski, G H, Lyman, J V, Chaney, H I, Saba, A S, Spiers, C, Klein

Publikováno v: Blood. 83:1903-1908

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f930eef3c1af3379d253f8a99824f872
https://doi.org/10.1182/blood.v83.7.1903.bloodjournal8371903

Zobrazit plný text záznamu

Non-Hodgkin's Lymphoma in the Older Person: A Review

Autor: O. F. Ballester, Lodovico Balducci, A. S. D. Spiers, Lynn C. Moscinski

Publikováno v: Journal of the American Geriatrics Society. 41:1245-1254

Objective: To study the epidemiology of non-Hodgkin's Lymphoma (NHL) in the older person and to explore treatment strategies for older persons with NHL. Design: Review of the English literature. Measurements: Incidence of NHL in patients of different

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26e5a117514ac21af6121914dc5e6f3a
https://doi.org/10.1111/j.1532-5415.1993.tb07310.x

Zobrazit plný text záznamu

Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma

Autor: John W. Hiemenz, G Ballester, P Wilcox, B Tan, Anastasios Raptis, T Fang, O F Ballester

Publikováno v: Bone marrow transplantation. 34(5)

In an attempt to induce a graft-versus-myeloma effect, we administered donor lymphocyte infusions (DLI) after high-dose therapy with autologous stem cell transplant rescue to seven patients with refractory or relapsed multiple myeloma. High-dose ther

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bdbc5622e83584bd77fbc69e5a58801
https://pubmed.ncbi.nlm.nih.gov/15286696

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání